Uveal Tract Anatomy & Physiology

Overview

The uvea (uveal tract) is the eye's middle, pigmented, and highly vascular layer, sandwiched between the outer fibrous coat (sclera and cornea) and the inner neurosensory retina. It is composed of three contiguous structures — the iris, ciliary body, and choroid — and inflammation of any part of it is called uveitis, causing eye redness, pain, photophobia, floaters, and blurred vision.¹

Gross Anatomy

The iris is the most anterior uveal structure, a pigmented diaphragm that controls pupil size via its sphincter and dilator muscles. The ciliary body lies just posterior to the iris root and has two functional parts: the pars plicata (folded anteriorly, producing aqueous humor and anchoring the lens zonules) and the pars plana (the smooth, flattened posterior extension that serves as the vitreous humor's attachment point). The choroid is the most posterior and extensive uveal structure, a densely vascular layer between the retina and sclera that supplies blood to the outer retina, including the photoreceptors and RPE.

This anatomic subdivision directly defines how uveitis is classified clinically: anterior uveitis affects the iris and ciliary body (the largest share of cases, 41-60%); intermediate uveitis affects the pars plana and peripheral retina (9-15%); posterior uveitis involves the choroid and/or retina (17-23%); and panuveitis involves all uveal layers simultaneously (7-32%).¹

Physiology & Function: Immune Privilege

The eye, including the uveal tract, maintains a state of immune privilege — a tightly regulated tolerance that limits potentially vision-threatening inflammation in response to minor antigenic challenge. This privilege is maintained through a combination of anatomical barriers (such as the blood-ocular barriers), local immunomodulatory mediators, regulatory immune-cell interactions, and anterior chamber-associated immune deviation (ACAID), a form of systemic immune tolerance specifically induced by antigen exposure within the eye.² Ocular immune privilege is best understood as a dynamic, conditional state rather than an absolute one: across conditions such as autoimmune uveitis, corneal transplantation, age-related macular degeneration, diabetic retinopathy, ocular tumors, and allergic conjunctivitis, disease is generally associated with partial disruption, remodeling, or exploitation of these privilege mechanisms rather than their complete loss.² These alterations vary by ocular compartment and clinical context but recurrently involve disrupted immune homeostasis, increased inflammatory signaling, altered leukocyte activity, impaired barrier integrity, and reduced local immune restraint.²

Clinical Correlations

Untreated uveitis, regardless of anatomic subtype, can cause cataract, glaucoma, macular edema, retinal detachment, and optic nerve damage — reflecting the uvea's direct anatomic and vascular connections to the lens, angle, retina, and optic nerve.¹ Uveitis predominantly affects adults 20-50 years old, and while a substantial proportion is idiopathic (27-51% in the US and Europe), 37-49% is associated with an identifiable systemic disease such as axial spondyloarthritis, underscoring why uveitis often warrants a systemic, not just ocular, workup.¹ Understanding which elements of immune privilege are preserved or disrupted in a given clinical setting can help explain why inflammation, transplantation, tumors, and allergy behave differently across ocular tissues, and may support more precise, immune-directed treatment approaches.²

Clinical Pearls

• Uveitis anatomic classification (anterior, intermediate, posterior, panuveitis) directly maps onto which uveal structure — iris/ciliary body, pars plana, choroid/retina, or all layers — is inflamed¹
• The pars plana, not the pars plicata, is the anatomic landmark defining intermediate uveitis and the site of vitreous base attachment¹
• Ocular immune privilege is a dynamic, conditional system — not an all-or-nothing state — maintained by anatomical barriers, local mediators, and ACAID-mediated tolerance²
• A substantial proportion of uveitis is linked to systemic disease, making a directed systemic review essential rather than optional¹

Common Pitfalls

• Treating "uveitis" as a single disease rather than a group of conditions defined by which anatomic uveal compartment is involved¹
• Confusing the pars plicata (aqueous production, zonules) with the pars plana (vitreous attachment, intermediate uveitis landmark)
• Assuming ocular immune privilege is either fully intact or completely absent, rather than understanding it as a graded, context-dependent state that can be partially disrupted²
• Omitting a systemic disease workup in uveitis patients, given the substantial proportion of cases linked to identifiable systemic conditions¹